Showing results (121-130 of 127) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Journal of the American College of Cardiology|May 20, 2021
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HFJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.Wiener Klinische Wochenschrift|December 3, 2020
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statementDiana Bonderman, Gerhard Pölzl, Klemens Ablasser, et al.Journal of Clinical Medicine|July 18, 2020
Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot SpotsMichaela Auer-Grumbach, Rene Rettl, Klemens Ablasser, et al.Scientific Reports|November 23, 2022
The systemic renin-angiotensin system in COVID-19Roman Reindl-Schwaighofer, Sebastian Hödlmoser, Oliver Domenig, et al.Journal of Clinical Medicine|March 14, 2026
Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide CohortNikita Ermolaev, Wolfgang N Löscher, Nicolas Verheyen, et al.The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.Pageof 13